News Hikma Pharmaceuticals PLC

Equities

HIK

GB00B0LCW083

Market Closed - London S.E. Other stock markets 11:35:05 2024-09-11 am EDT			5-day change	1st Jan Change
1,932.00 ^GBX	+0.78%		-2.28%	+7.99%

Sep. 10	Hikma Pharmaceuticals completes acquisition of Xellia's FDF business	AN
Sep. 10	Hikma Closes Purchase of Xellia Pharmaceuticals' US Finished Dosage Form Business	MT

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Xellia Pharmaceuticals announces the completion of the divestment of its US-based institutional activities to Hikma Pharmaceuticals	09:56am	AQ
Hikma Pharmaceuticals completes acquisition of Xellia's FDF business	Sep. 10	AN
Hikma Closes Purchase of Xellia Pharmaceuticals' US Finished Dosage Form Business	Sep. 10	MT
Berenberg raises Hikma Pharmaceuticals to 'buy'	Sep. 03	AN
FTSE 100 called up ahead of post-US Labor Day data	Sep. 03	AN
Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention Day	Aug. 21	AQ
Hikma Pharmaceuticals - KLOXXADO 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 months	Aug. 16	AQ
Hikma Pharmaceuticals plc Announces the Shelf-Life Extension of KLOXXADO Nasal Spray 8mg from 24 to 36 Months	Aug. 15	CI
Ex-dividend day for interim dividend	Aug. 14	FA
Hikma executive Bassam Kanaan sells 45,000 shares	Aug. 13	AN
Peel Hunt cuts Spirax to 'hold'	Aug. 13	AN
HIKMA PHARMACEUTICALS : H1 beat; guidance upgraded; markets jubilant	Aug. 09
London's FTSE 100 ends lower as top companies trade ex-dividend	Aug. 08	RE
London's FTSE 100 inches lower as companies trade ex-dividend; earnings cap declines	Aug. 08	RE
Hikma Pharmaceuticals raises guidance as first-half profit jumps 43%	Aug. 08	AN
Transcript : Hikma Pharmaceuticals PLC, H1 2024 Earnings Call, Aug 08, 2024	Aug. 08
Hikma Pharmaceuticals Books Higher H1 Attributable Profit, Revenue	Aug. 08	MT
Earnings Flash (HIK.L) HIKMA PHARMACEUTICALS Posts H1 EPS $1.27	Aug. 08	MT
Hikma Pharmaceuticals PLC Revises Group Earnings Guidance for the Full Year of 2024	Aug. 08	CI
Hikma Pharmaceuticals PLC Recommends an Interim Dividend, Payable on 20 September 2024	Aug. 08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

HIKMA PHARMACEUTICALS : H1 beat; guidance upgraded; markets jubilant

August 09, 2024 at 04:18 am EDT